Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve ...

France-based Danone and Michelin, DMC Biotechnologies in the U.S., and Crédit Agricole Centre France, agreed to create the “Biotech Open Platform” to advance the development of advanced fermentation ...

$250 million (USD) plant will help produce transformational cell and gene therapies on a global scale Creating readiness for first production runs of potential commercial launches, including ...

If you want to paint a picture of the biotech landscape, Amrit Chaudhuri would be among the first people you approach for insight. Now CEO of SmartLabs, he began his career with eight years dedicated ...

HCW Biologics Inc. and WY Biotech Co., Ltd. have finalized a licensing agreement for the development and commercialization of HCW11-006, a novel immunotherapy targeting age-related diseases and cancer ...

Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system. “With ...